Brookline, MA, United States of America

Deborah H Meshulam

This inventor holds 5 USPTO granted patents and 6 published patent applications, plus 5 CIPO patents and 3 EPO patents. Top assignee: Immunogen, Inc.. Active years: 2010-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Deborah H Meshulam. Retrieved from https://idiyas.com/inventor/deborah-h-meshulam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 89(Granted Patents)


Company Filing History:


Years Active: 2010-2022

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Deborah H Meshulam

Introduction

Deborah H Meshulam is a prominent inventor based in Brookline, MA (US). She has made significant contributions to the field of drug development, holding a total of 5 patents. Her work focuses on creating innovative processes for preparing drug conjugates that enhance therapeutic efficacy.

Latest Patents

One of her latest patents is titled "Process for preparing purified drug conjugates." This invention provides a detailed methodology for preparing a cell-binding agent that is chemically coupled to a drug. The process involves covalently attaching a linker to a cell-binding agent, followed by a purification step, conjugating a drug to the cell-binding agent, and a subsequent purification step. This innovative approach aims to improve the effectiveness of drug delivery systems.

Career Highlights

Deborah H Meshulam is currently associated with Immunogen, Inc., where she continues to advance her research and development efforts. Her expertise in drug conjugates has positioned her as a key figure in the pharmaceutical industry, contributing to the development of targeted therapies.

Collaborations

Throughout her career, Deborah has collaborated with notable colleagues, including Yong Dai and Yong Wang. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in drug development.

Conclusion

Deborah H Meshulam's contributions to the field of drug conjugates exemplify her commitment to innovation and excellence in pharmaceutical research. Her work continues to impact the industry positively, paving the way for future advancements in drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…